Dominik Ellenrieder
Chairman bij Senspec GmbH
Vermogen: 91 M $ op 31-03-2024
Profiel
Dominik Ellenrieder was the founder of Kuros Biosurgery Holding AG, founded in 2002, where he held the title of Director-Executive Board from 2010 to 2012.
He was also the founder of Kuros Therapeutics AG, founded in 2000, where he served as Chairman from 2000 to 2002.
Currently, Mr. Ellenrieder holds several positions.
Since 2006, he has been Chairman of SenTec AG.
He is also Chairman of Senspec GmbH, Nexmed Holding AG, Le Grand Hotel Chandolin SA, and Operating Partner at Endeavour Vision SA since 2007.
In his former roles, Mr. Ellenrieder served as Chairman of Symetis SA from 2015 to 2017.
He was Vice Chairman of Kuros Biosciences Ltd.
and Kuros Biosciences AG from 2003 to 2015.
He also held the position of Vice Chairman at Medartis AG from 2000 to 2021.
Additionally, he was a Director at Straumann Holding AG from 2001 to 2014 and an Independent Non-Executive Director at Medartis Holding AG from 2000 to 2023.
He has also worked at Stratec Medical AGs, Sulzer Medica, and Protek AG in various roles.
Mr. Ellenrieder's education includes an MBA from Boston University, an undergraduate degree from the University of Basel, and an MBA from the Graduate School of Business Administration Zürich.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MEDARTIS HOLDING AG
7.45% | 31-12-2022 | 921 035 ( 7.45% ) | 91 M $ | 31-03-2024 |
Actieve functies van Dominik Ellenrieder
| Bedrijven | Functie | Begin |
|---|---|---|
Endeavour Vision SA
 Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Corporate Officer/Principal | 01-09-2007 |
SenTec AG
 SenTec AG Electronic Equipment/InstrumentsElectronic Technology SenTec AG develops and markets medical related products. The company was founded on July 15, 1999 and is headquartered in Therwil, Switzerland. | Chairman | 24-02-2012 |
| Senspec GmbH | Chairman | - |
| Nexmed Holding AG | Chairman | - |
| Le Grand Hotel Chandolin SA | Chairman | - |
Eerdere bekende functies van Dominik Ellenrieder
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDARTIS HOLDING AG | Director/Board Member | 01-04-2023 |
| Medartis AG | Director/Board Member | 01-01-2021 |
| SYMETIS SA | Chairman | 01-01-2017 |
| KUROS BIOSCIENCES AG | Director/Board Member | 01-01-2015 |
| ░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Dominik Ellenrieder
| Boston University | Masters Business Admin |
| University of Basel | Undergraduate Degree |
| Graduate School of Business Administration Zürich | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| STRAUMANN HOLDING AG | Health Technology |
| MEDARTIS HOLDING AG | Health Technology |
| KUROS BIOSCIENCES AG | Health Technology |
| Bedrijven in privébezit | 14 |
|---|---|
| Stratec Medical AGs | |
| Sulzer Medica | Health Technology |
Kuros Biosurgery Holding AG
 Kuros Biosurgery Holding AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosurgery Holding AG operated as a medical technology company. It engaged in the development of biologic and biomaterial-based product candidates for localized therapy in trauma, spine and wound care. The company was founded by Marion Bavand, Didier Cowling, Dominik Ellenrieder, and Jeffrey Hubbel on April 3, 2008 and was headquartered in Zurich, Switzerland. | Commercial Services |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Symetis SA develops minimally invasive heart valve replacement devices. Its products include ACURATE TA and ACURATE neo. The company was founded by Simon P. Hoerstrup and Gregor Zünd on September 5, 2001 and is headquartered in Ecublens, Switzerland. | Health Technology |
Endeavour Vision SA
Endeavour Vision SA Investment ManagersFinance Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry. | Finance |
SenTec AG
SenTec AG Electronic Equipment/InstrumentsElectronic Technology SenTec AG develops and markets medical related products. The company was founded on July 15, 1999 and is headquartered in Therwil, Switzerland. | Electronic Technology |
| Kuros Therapeutics AG | |
Qgel SA
 Qgel SA BiotechnologyHealth Technology Qgel SA engages in drug discovery. The private company is based in Lausanne, Switzerland. The Swiss company was founded in 2009 by Matthias Lütolf and Colin Sanctuary. Colin Sanctuary has been the CEO since 2009. | Health Technology |
| Senspec GmbH | |
| Nexmed Holding AG | |
| Le Grand Hotel Chandolin SA | |
Kuros Biosciences AG
 Kuros Biosciences AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosciences AG is a Swiss company that specializes in developing innovative solutions for targeted and controlled bone healing. The private company is based in Schlieren, Switzerland. The company's mission is to eliminate non-unions and improve patient rehabilitation. | Commercial Services |
| Medartis AG | |
| Protek AG |
